Evogene (EVGN) Receivables - Net (2016 - 2025)
Evogene (EVGN) has disclosed Receivables - Net for 10 consecutive years, with $317000.0 as the latest value for Q4 2025.
- Quarterly Receivables - Net fell 70.94% to $317000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $317000.0 through Dec 2025, down 70.94% year-over-year, with the annual reading at $317000.0 for FY2025, 70.94% down from the prior year.
- Receivables - Net hit $317000.0 in Q4 2025 for Evogene, down from $1.1 million in the prior quarter.
- In the past five years, Receivables - Net ranged from a high of $1.1 million in Q4 2024 to a low of $281000.0 in Q4 2021.
- Historically, Receivables - Net has averaged $478800.0 across 5 years, with a median of $348000.0 in 2022.
- Biggest five-year swings in Receivables - Net: soared 205.6% in 2024 and later crashed 70.94% in 2025.
- Year by year, Receivables - Net stood at $281000.0 in 2021, then increased by 23.84% to $348000.0 in 2022, then grew by 2.59% to $357000.0 in 2023, then skyrocketed by 205.6% to $1.1 million in 2024, then plummeted by 70.94% to $317000.0 in 2025.
- Business Quant data shows Receivables - Net for EVGN at $317000.0 in Q4 2025, $1.1 million in Q4 2024, and $357000.0 in Q4 2023.